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Abstract
Modulation of endogenous neurogenesis is regarded as a promising challenge in neuroprotection. In the rat model of
hippocampal neurodegeneration obtained by Trimethyltin (TMT) administration (8 mg/kg), characterised by selective
pyramidal cell loss, enhanced neurogenesis, seizures and cognitive impairment, we previously demonstrated a proliferative
role of exogenous neuropeptide Y (NPY), on dentate progenitors in the early phases of neurodegeneration. To investigate
the functional integration of newly-born neurons, here we studied in adult rats the long-term effects of
intracerebroventricular administration of NPY (2 mg/2 ml, 4 days after TMT-treatment), which plays an adjuvant role in
neurodegeneration and epilepsy. Our results indicate that 30 days after NPY administration the number of new neurons was
still higher in TMT+NPY-treated rats than in control+saline group. As a functional correlate of the integration of new neurons
into the hippocampal network, long-term potentiation recorded in Dentate Gyrus (DG) in the absence of GABAA receptor
blockade was higher in the TMT+NPY-treated group than in all other groups. Furthermore, qPCR analysis of Kruppel-like
factor 9, a transcription factor essential for late-phase maturation of neurons in the DG, and of the cyclin-dependent kinase
5, critically involved in the maturation and dendrite extension of newly-born neurons, revealed a significant up-regulation of
both genes in TMT+NPY-treated rats compared with all other groups. To explore the early molecular events activated by
NPY administration, the Sonic Hedgehog (Shh) signalling pathway, which participates in the maintenance of the neurogenic
hippocampal niche, was evaluated by qPCR 1, 3 and 5 days after NPY-treatment. An early significant up-regulation of Shh
expression was detected in TMT+NPY-treated rats compared with all other groups, associated with a modulation of
downstream genes. Our data indicate that the neurogenic effect of NPY administration during TMT-induced
neurodegeneration involves early Shh pathway activation and results in a functional integration of newly-generated
neurons into the local circuit.
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Introduction
Hippocampal neurogenesis is a highly regulated process which,
throughout adult mammalian life, generates new cells differenti-
ating into functionally integrated granular neurons. As this form of
brain plasticity can be influenced by endogenous and exogenous
factors, as well as by pathological conditions [1–3] including
neurodegenerative diseases and epilepsy [1,4], the modulation of
adult neurogenesis constitutes an attractive research field. In
particular, the pharmacological targeting of endogenous mecha-
nisms may offer clues useful to the development of novel
therapeutic strategies in the damaged brain.
In this regard, recent evidence largely supports the involvement
of neuropeptide Y (NPY) in the modulation of endogenous
neurogenesis [5–7]. NPY is a 36 amino acid polypeptide
neurotransmitter widely distributed in the mammalian central
nervous system (CNS), that exerts a role in various physiological
functions, including the regulation of blood pressure, circadian
rhythms, feeding behaviour, anxiety, memory processing and
cognition [5–7]. Within the dentate gyrus (DG), NPY is expressed
by a subpopulation of GABAergic interneurons located in the
hilus, which innervate the granule cell layer in close proximity to
the subgranular zone (SGZ), thus contributing to the physiological
control of hippocampal progenitor cells [8]. The pro-neurogenic
role of exogenous NPY on hippocampal neurogenic niche has
been evidenced both in vitro [9–11] and in vivo [12]. This effect
appears to be mediated specifically by the Y1 receptors, and to
involve the ERK1/2 signalling pathway [9] and is restricted to
nestin, beta tubulin and doublecortin-expressing progenitors
[9,13].
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The NPY system is also involved in epilepsy [14,15], which is
known to increase adult neurogenesis acutely [4]. In this respect, a
possible anticonvulsant and neuroprotective role has been
proposed [14,16]. Changes in hippocampal NPY levels have been
observed in GABAergic interneurons and mossy fibres in both
experimental models and human temporal lobe epilepsy (TLE)
[14,15], including the model of hippocampal neurodegeneration
and TLE induced by Trimethyltin (TMT) administration [17–20].
TMT is an organotin compound with neurotoxicant effects
selectively involving the limbic system and especially marked in the
hippocampus. Rats exposed to TMT show severe loss of
pyramidal neurons in the CA3/hilus and CA1 hippocampal
subfields, with selective sparing of GABAergic interneurons
expressing parvalbumin and calretinin [17,18,21–24]. Neuronal
damage shows a subacute pattern developing over three weeks
[25] and is associated with astroglial and microglial activation [26–
29], enhanced neurogenesis [30], seizures and cognitive impair-
ment [17,18]. While the mechanisms by which TMT induces
neurodegeneration are still not conclusively clarified, many
hypotheses suggest that neuronal damage could be largely
dependent on calcium overload, possibly as a consequence of its
release from intracellular stores [24,31,32].
TMT is thus widely considered a useful instrument to study
neuronal and glial factors involved in selective neuronal death, as
well as the molecular mechanisms leading to hippocampal
neurodegeneration (including neuroinflammation, excitotoxicity,
mitochondrial dysfunction and oxidative stress). It also offers a
valuable tool to study cell-cell interactions and signalling pathways
that modulate injury-induced neurogenesis, including the involve-
ment of newly-generated neurons in the possible repair processes
[18,33].
In this regard, we previously studied the role of exogenous NPY
[34] on the hippocampal neurogenic niche of TMT-treated rats.
In particular, our previous data indicated a neuroprotective and
neurogenic role of exogenous NPY in the early phases of TMT-
induced neurodegeneration, mediated by the up-regulation of Bcl-
2, Bcl-2l, Bdnf, Sox-2, NeuroD1, Noggin and Doublecortin genes,
and accompanied by the early induction of Y1, Y2 and Y5
receptor mRNA [34].
Since the early molecular events triggered by NPY administra-
tion and mediating its neurogenic effect have not been definitively
clarified, in the present study we explored the possible role of
molecular pathways critically involved in the establishment and
maintenance of the adult hippocampal neurogenic niche, such as
that involving Sonic Hedgehog (Shh) signalling. Shh is known to
participate in CNS development and recent evidence highlights its
role also in the adult brain [35], where it regulates both cell
proliferation [36,37] and the production of growth and angiogenic
factors [38]. In particular it appears to be crucially required for
DG progenitor cell proliferation via primary cilia [35,39,40],
microtubule-based organelles functionally implicated in many
developmental processes [41].
The efficacy of adult neurogenesis modulation in achieving
structural/functional repair depends on the survival and functional
integration of newly-generated neurons into neuronal circuitries.
The long-term neurogenic effects of intracerebroventricular (i.c.v.)
NPY administration were therefore investigated by evaluating
morphological, molecular and functional correlates of newly-born
neuron integration into the DG network.
Materials and Methods
Ethics Statement
All animal procedures were approved by the Ethics Committee
of the Catholic University and were fully compliant with The
Italian Ministry of Health guidelines (Legislative Decree No. 116/
1992) and European Union (Directive No. 86/609/EEC) legisla-
tion on animal research. Efforts were made to limit the number of
animals used and to minimise their suffering. ARRIVE guidelines
were followed.
Animal Treatment
Adult female Wistar rats (250 g) received a single intra-
peritoneal (i.p.) injection of TMT chloride (Sigma, St Louis,
MO) dissolved in saline at a dose of 8 mg/Kg body weight in a
volume of 1 ml/kg body weight, as previously described
[21,22,25]; control (CTRL) rats received the same volume of
saline. On post-treatment day 4, animals were divided into
different experimental groups: CTRL+saline, CTRL+NPY,
TMT+saline, TMT+NPY and, under deep anaesthesia, they
received i.c.v. administration of NPY (2 mg/2 ml), or the same
volume of saline. The animals were anaesthetised with diazepam
2 mg/100 g i.p., followed by ketamine 4 mg/100 g (intramuscu-
lar). As previously described [34], they were mounted on a
stereotaxic frame; a small parietal hole was made in the skull and a
single suspension of NPY (AnaSpec, San Jose, CA, USA) or the
same volume of saline, was slowly injected using a Hamilton
syringe and the following coordinates: A.P.:+0.80; L.:21.6; P.:–3.4
from the dura mater [42]. The dose of NPY was chosen according
to previous studies [34].
In some experiments CTRL (n = 3) and TMT-treated rats
(n = 3) were injected with scrambled NPY peptide (Tocris
Biosciences – R&D Systems Company) (4 days after TMT-
treatment), at the same dosage as NPY-treated groups (2 mg/2 ml)
and sacrificed 1 and 3 days after scrambled NPY treatment.
No body weight variation depending on NPY-administration
was observed, as previously described [34].
Animals were returned to their cages and housed on a 12 h
light/dark cycle with free access to food and water. One hour after
surgical procedures all animals received bromodeoxyuridine
(BrdU) (50 mg/kg dissolved in a saline solution 0.1 M NH4OH)
i.p. BrdU was administered once a day for 5 consecutive days.
This schedule was chosen to reduce possible long-term BrdU
dilution effects.
Immunocytochemistry
Rats intended for histology and immunocytochemistry were
sacrificed 30 days after NPY or saline i.c.v. administration. Under
deep anaesthesia (ketamine/diazepam 1:1 i.p.), the animals were
perfused with 4% phosphate-buffered saline (PBS) paraformalde-
hyde, the brains were removed from the skull and 40 mm serial
sagittal sections were collected in PBS and used for Nissl-staining
or immunocytochemistry.
For BrdU labelling, sections were incubated for 30 min with 2N
HCl at 37uC for DNA denaturation, for 15 min with 5% normal
goat serum at 37uC and overnight with rat monoclonal anti-BrdU
antibody (Abcam, Cambridge, UK, 1:500). The reaction was
developed with an avidin-biotin peroxidase complex (ABC
method, Vector Burlingame, CA). 3,39-diaminobenzidine (Sigma,
St. Louis, MO) was used as a chromogen.
Mature newly-born neurons were identified by double labelling
with the proliferation marker BrdU and the mature neuron
marker NeuN (Chemicon, Temecula, CA, 1:1000, overnight at
4uC) and revealed using donkey anti-mouse cyanine-conjugated
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secondary antibody (Cy3, 1:400, 1 h at room temperature, Jackson
Immunoresearch Laboratories, West Grove, PA), while BrdU
labelling was revealed with FITC conjugated goat anti-rat
secondary antibody (Vector, UK, 1:200, 1 h at room tempera-
ture). Controls were prepared by omitting the primary antibody.
The co-localisation of the different markers was examined with a
Zeiss LSM 510 META confocal laser scanning microscopy system
(Zeiss, Oberkochen, Germany).
Quantitative Analysis
Since it is well known that new granule cells derive from
dividing progenitors in the SGZ and migrate approximately 2 cell
body widths from the SGZ into the granule layer (GL), where they
become functionally integrated into the hippocampal circuit [43],
only round, regularly shaped BrdU-positive nuclei located in the
DG GL, without signs of nuclear fragmentation, were counted in
the four experimental groups (CTRL+saline: n = 7, CTRL+NPY:
n = 6, TMT+saline: n = 8, TMT+NPY: n = 7). BrdU-labelled cells
with morphological characteristics of glial precursors, i.e. small
(diameter ,8 mm), irregularly shaped cell bodies, were excluded,
as previously described [30].
The optical fractionator stereological method [44] was used to
obtain unbiased estimates of total BrdU-positive nuclei in the DG,
using the Stereo Investigator system (Stereo Investigator software,
Version 9, MicroBrightField Europe, Magdeburg, Germany). A
stack of MAC 6000 controller modules (MBF Bioscience, Williston
VT, USA) was configured to interface a Nikon Eclipse 80i
microscope with a motorised stage and a digital colour camera
(MBF Bioscience q imaging) with a Pentium II PC workstation. A
three-dimensional optical dissector counting probe (x, y, z
dimension of 130 mm 6 150 mm 6 10 mm respectively) was
applied to a systematic random sample of sites in the region of
interest at a magnification of 406. To count BrdU-positive cells in
the DG, 1-in-7 series of sagittal sections were taken through the
dorsal hippocampus along the septo-temporal axis, from 0.9 to
3.4 mm lateral to the midline, according to Paxinos and Watson’s
atlas [42].
BrdU/NeuN double-stained cells in the DG were quantified in
the four experimental groups (CTRL+saline: n = 3, CTRL+NPY:
n = 3, TMT+saline: n = 3, TMT+NPY: n = 3) using z-scan
confocal microscopy at 40X magnification. The entire length of
the DG (upper and lower blades) was evaluated through the septo-
temporal axis of the hippocampus in 1-in-12 series of sections, as
previously described [34,45–47]. Each cell was examined with a
multi-channel configuration and only those cells for which the
nucleus was unequivocally associated with the neuronal marker
were considered as positive [46]. Quantitative analysis was
performed as previously described [21,22,26,30,48]. The number
of double-labelled cells was counted manually by an experimenter
who was not informed of the group assignment. Estimates of the
total number of cells positive for each marker were obtained using
the following formula: E = k SN, where E is the estimate of the
total number of stained cells in each case, SN is the sum of n
values in the n sections considered, and k indicates that every kth
section was considered (k = 12). N was corrected according to
Abercrombie’s formula: N = n t/(t+D), where n is the number of
cells counted in each section, t is the section thickness, and D is the
mean diameter of the cells [49].
The quantification of double-stained cells was expressed as the
percentage of double-labelled cells in relation to the total number
of BrdU-positive cells or as the total number of double-labelled
cells.
Long-term Potentiation Recordings
Electrophysiological recordings and long-term potentiation
(LTP) evaluation at the medial perforant path (MPP)-dentate
granule cell (DGC) synapses were performed in slices from rats
belonging to the four experimental groups, sacrificed 30–40 days
after NPY-treatment. In particular, coronal hippocampal slices
(400 mm thick) were obtained according to standard procedures
[50–52] from 20 rats (CTRL+saline: n = 5, TMT+saline: n = 5,
CTRL+NPY: n = 5, TMT+NPY: n = 5). Operators were unaware
of the origin of the experimental group being processed.
The rats were anaesthetised with isoflurane and decapitated.
The brain was rapidly removed and put in ice-cold cutting solution
containing in mM: 124 NaCl, 3.2 KCl, 1 NaH2PO4,
26 NaHCO3, 2 MgCl2, 1 CaCl2, 10 glucose, 2 Na-pyruvate,
and 0.6 ascorbic acid (pH 7.4, 95% O2/5% CO2). Slices were
cut with a vibratome (VT1000S, Leica Microsystems), incubated
in the cutting solution at 30–32uC for at least 60 min, and then
stored in the same solution at room temperature until use.
For electrophysiological recordings, slices were transferred to a
submerged recording chamber and continuously perfused with
artificial cerebrospinal fluid (aCSF) containing (in mM): 124 NaCl,
3.2 KCl, 1 NaH2PO4, 1 MgCl2, 2 CaCl2, 26 NaHCO3, and 10
glucose (pH 7.4, 95% O2/5% CO2). The flow rate was kept at
1.5 ml/min with a peristaltic pump (Minipuls 3, Gilson, Villiers,
France), and bath temperature was maintained at 30–32uC with
an in-line solution heater and temperature controller (TC-344B,
Warner Instruments, Hamden, CT, USA).
Field excitatory postsynaptic potentials (fEPSPs) were recorded
in the hippocampal DG. For this purpose, a stimulating bipolar
tungsten electrode (Warner Instruments) connected to a S11 Grass
stimulator (Grass Instruments, Quincy, MA) was positioned in the
MPP, and a glass capillary microelectrode filled with aCSF (tip
resistance 2–5 MV) was placed in the middle third of the
molecular layer of the DG (upper blade) and connected to a
MultiClamp 700A amplifier (Molecular Devices, Sunnyvale, CA,
USA). Data acquisition and stimulation protocols were performed
with the Digidata 1440 Series interface and pClamp 10 software
(Molecular Devices). Data were filtered at 1 kHz, digitised at
10 kHz, and analysed both online and offline.
Hippocampal subfields were identified and electrodes were
positioned with the aid of 4X and 40X water immersion objectives
on an upright microscope (BX5IWI, Olympus) equipped with a
video camera (C3077-71 CCD, Hamamatsu Photonics, Japan).
Isolation of the MPP was confirmed by assessing paired-pulse
depression (PPD) (interstimulus interval, 50 ms) at MPP-DGC
[53,54]. The stimulation intensity that produced one-third of the
maximal response was used for the test pulses and high frequency
stimulation protocol (HFS).
After 10 min of stable baseline responses to test stimulations
delivered once every 20 s, LTP was induced with a standard high
frequency stimulation (HFS) paradigm consisting of 4 trains of 50
stimuli at 100 Hz (500 ms each) repeated every 20 seconds
[53,55]. Responses to test pulse were recorded every 20 seconds
for 30 minutes to assess LTP. The amplitude of fEPSPs at 30
minutes was averaged from values obtained during the last 5
minutes of post-HFS recordings (from minute 25 to minute 30).
LTP magnitude was expressed as the percentage change in the
mean fEPSP peak amplitude normalised to baseline values (i.e.
mean values for the last 10 minutes of recording before HFS, taken
as 100%). The fEPSP amplitude was measured from baseline to
peak. At the end of LTP recording, all slices included in the study
exhibited stable increases of at least 10% in fEPSP amplitude.
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Gene Expression Analysis
Animals intended for quantitative real-time PCR (qPCR) were
sacrificed by decapitation after deep anaesthesia (ketamine/
diazepam 1:1 i.p.) 1, 3, 5 and 30 days after NPY, scrambled
NPY peptide or saline i.c.v. administration (CTRL+saline: n = 3,
CTRL+NPY: n = 3, TMT+saline: n = 3, TMT+NPY: n = 3). The
hippocampus homolateral to the injection site was removed and
processed for total RNA isolation.
Quantitative real time PCR (qPCR) was used to amplify, in the
four experimental groups, the following genes: Sonic hedgehog
(Shh), Patched 1 (Ptch1), Cyclin D1 (Ccnd1), Kinesin family
member 3a (Kif3a) 1, 3, 5 days following NPY administration,
Kruppel-like factor 9 (Klf9) and Cyclin Dependent Kinase 5
(Cdk5) 30 days following NPY administration.
The expression of NPY specific receptors (NpyR) NpyR-1, -2
and -5 was analysed by qPCR in the four experimental groups and
in scrambled NPY-treated animals 1 and 3 days after NPY
treatment.
Three animals per experimental group were used for the gene
expression analysis. The entire qPCR protocol has already been
described in detail elsewhere [34]. Briefly, total RNA was isolated
from the entire hippocampus of each animal using Trizol reagent
(Invitrogen, Carlsbad, CA, USA) and purified using the RNeasy
MiniElute Cleanup Kit (Qiagen, Valencia, CA, USA), according
to the manufacturer’s instructions, followed by DNAse digestion
(Invitrogen). Two-step reverse transcription and qPCR were
carried out as previously described [56]. The oligonucleotide
primers were designed using the Primer 3 software (http://
primer3 sourceforge.net/; primer sequences can be found in Table
S1). The 22DDCt method was applied to calculate the relative
quantity (RQ) of gene expression using the housekeeping gene
glyceraldehyde-3-phosphate dehydrogenase (Gapdh) for data
normalisation [56].
Statistical Analysis
For statistical analysis, group differences (TMT vs. control and
NPY vs. saline) were evaluated using analysis of variance (two-way
ANOVA; StatView software); when appropriate, post hoc compar-
isons were made using Bonferroni’s test, with a significance level of
p,0.05; data are expressed as mean 6 S.E.M.
In order to assess the statistical significance of the gene
expression changes for each gene in each experimental group,
an unpaired t-test was used to compare the DCt values across the
replicates, setting the p-value cut-off at 0.05.
Student’s t-test was also used for statistical comparison of data
obtained from LTP recordings and data are expressed as mean 6
S.E.M.
Results
NPY-induced Modulation of Hippocampal Neurogenesis
Results in the Functional Integration of Newly-generated
Neurons into the Local Circuit in TMT-treated Rats
The pattern of TMT-induced neuronal death was consistent
with previous observations, as expected [17,25]. Histological
observation of Nissl-stained sections showed neuronal loss mainly
localised in the CA3/hilus and CA1 hippocampal subfields of both
groups of TMT-treated animals [21,22,25] (Fig. 1 A–D).
Light microscopy analysis of BrdU-labelled sections revealed the
presence of round and regular BrdU-positive nuclei in the DG of
all experimental groups (Fig. 2 Aa–d), being more numerous in the
TMT+NPY-treated animals (Fig. 2 Ad).
Unbiased quantitative analysis of DAB-stained BrdU-positive
cells, performed to determine whether NPY-induced enhancement
of dentate neurogenesis in TMT-treated rats is still evident 30 days
after treatment, showed a significant effect of both TMT and NPY
treatments (Two-way ANOVA, F1,24 = 4.9 for saline vs. NPY, p,
0.05, F1,24 = 4.8 for CTRL vs. TMT p,0.05); in particular post hoc
comparison indicated that the number of newly-generated cells
was significantly higher in the GL of TMT+NPY-treated rats than
in the CTRL+saline group (Bonferroni post hoc: p,0.01). No
significant statistical difference was evidenced between TMT+
NPY and TMT+saline-treated rats (Two-way ANOVA
F1,24 = 4.9, Bonferroni post hoc p.0.05), TMT+saline-treated
animals and both CTRL groups (Two-way ANOVA F1,24 = 4.8;
Bonferroni post hoc p.0.05) or between the CTRL+saline and
CTRL+NPY groups (two-way ANOVA F1,24 = 4.9, Bonferroni
post hoc p.0.05) (Fig. 2 B).
To determine how many of the newly-generated cells within the
DG differentiate into neurons, we performed confocal microscopy
analysis of double-stained BrdU-positive cells co-expressing the
mature neuronal marker NeuN. More numerous BrdU/NeuN-
positive cells were detectable in TMT+NPY-treated rats (Fig. 3
Ad). Quantitative analysis of BrdU/NeuN double-labelled cells
indicated that, while a significantly higher number of double-
stained cells was evidenced in the TMT+NPY treated group
compared with all other groups (see Table S2), the percentage of
BrdU/NeuN double-stained cells in relation to the total number of
BrdU-positive cells was unchanged among the various experi-
mental groups (two-way ANOVA F1,8 = 1,6 p.0.05 for TMT vs.
CTRL; two-way ANOVA F1,8 = 0,15 p.0.05 for NPY vs. saline)
(Fig. 3 B).
It is known that, in the time window ranging from 30 to 45 days
after mitosis, newly-generated neurons exhibit peculiar features,
including low sensitivity to GABAergic inhibition that distinguish
them from mature granule neurons in the DG [53,57–59]. To
assess the functional integration of newly-born neurons into the
DG network, we studied LTP at the MPP-DGC synapses in slices
from rats belonging to the four experimental groups perfused with
normal aCSF, i.e., without GABAA receptor antagonists (aCSF-
LTP). aCSF-LTP is fairly weak compared to that usually recorded
in the presence of GABAA receptor blockers, but the potentiation
that is observed can be attributed specifically to the newly-
generated neurons [60,61].
In hippocampal slices from CTRL+saline rats fEPSP ampli-
tudes measured 30 min after HFS stimulation were only
119.964.2% of baseline values (n = 10 slices from 5 animals;
Fig. 4). Comparison with the other experimental groups revealed
that aCSF-LTP values were significantly higher in the TMT+
NPY-treated group (132.064.1%; n = 13 slices from 5 animals)
than in all the other groups (TMT+saline: 118.964.3%, n = 10
slices from 5 animals; CTRL+NPY: 119.465.0%, n = 10 slices
from 5 animals; TMT+NPY vs. TMT+saline or CTRL+NPY or
CTRL+saline p,0.05), while no significant differences were
detectable when comparing TMT+saline vs. CTRL+NPY or
CTRL saline (p.0.05; Fig. 4 B), and CTRL+NPY vs. CTRL+
saline (p.0.05, Fig. 4 B).
In order to analyse molecular correlates of the maturation and
integration of newly-born granular cells in the DG network we
evaluated the expression of the transcription factor Klf9, essential
for late-phase neuronal maturation during adult hippocampal
neurogenesis [62], 30 days after NPY administration. Expression
of neural-specific kinase Cdk5, known to play a key role in synapse
formation and neuronal maturation during adult neurogenesis
[63], was also evaluated at the same time point.
qPCR revealed a significant up-regulation of the Klf9 gene in
TMT+NPY-treated rats compared with CTRL+saline (p,0.05)
(Fig. 5; Table S3). A slight and barely significant upregulation
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(p = 0.05) was also observed in rats treated with NPY alone
(CTRL+NPY) at the same time point (Fig. 5). Similarly, an
increase in Cdk5 gene expression was evident in the TMT+NPY
group compared with CTRL+saline (p,0.05) (Fig. 5; Table S3).
Early Molecular Events Activated by NPY Administration
Involve Sonic Hedgehog Signalling Pathway Modulation
To investigate the early molecular events mediating NPY-
induced neurogenic effects, we evaluated the expression of Shh
and its downstream genes, Ptch1, Kif3a and Ccnd1, in the early
phases following NPY administration, namely 1, 3 and 5 days after
neuropeptide treatment. It is well known that the canonical Shh
signalling pathway includes its binding to the Ptch1 receptor,
which relieves the Ptch-mediated inhibition of the Smo receptor,
which in turn induces a recruitment of Gli transcription factors,
resulting in increased expression of Ccnd1 [64]. Genes encoding
the intraflagellar transport machinery (including Kif3a) are also
required for Shh signalling [65].
One day after NPY administration a statistically significant
increase in Shh expression was observed in the TMT+NPY group,
when compared with TMT+saline and both CTRL groups
(TMT+NPY vs. TMT+saline p,0.001; TMT+NPY vs. CTRL+
saline p,0.05; TMT+NPY vs CTRL+NPY p,0.001), accompa-
nied by a significantly increased expression of two Shh
downstream genes, namely Kif3a (TMT+NPY vs. CTRL+saline
p,0.05) and Ccnd1 (TMT+NPY vs. CTRL+saline or CTRL
NPY p,0.001) (Fig. 6, Table S3). At the same time point a
significant upregulation of Shh expression was also detectable in
the TMT+saline group when compared with CTRL+saline (p,
0.05), associated with the concomitant upregulation of Ptch1 and
Kif3a (TMT+saline vs CTRL+saline p,0.05) (Fig. 6, Table S3).
Shh expression did not show any significant change in CTRL+
NPY-treated animals (CTRL+NPY vs CTRL+saline p.0.05) at
this time point, though a significant upregulation of downstream
genes Ptch1 (p,0.05) and Ccnd1 (p,0.001) was detectable when
compared with CTRL+saline, suggesting that a modulation of the
Shh signalling pathway also occurred in this experimental group
(Fig. 6, Table S3).
Three days after NPY administration, Shh mRNA levels were
still higher in the TMT+NPY and TMT+saline groups, when
compared with CTRL+saline (p,0.05). At this time point a
significant transient increase in Shh expression was also observed
in the CTRL+NPY group compared with CTRL+saline (p,
0.001). No significant variation of Ptch1, Kif3a and Ccnd1
expression was detectable among the different experimental
groups (p.0.05) (Fig. 6, Table S3).
Five days after NPY administration Shh expression was still
significantly upregulated in the TMT+NPY group, when com-
Figure 1. TMT-induced neuronal loss in the rat hippocampus. Micrographs of Nissl-stained 40 mm sagittal sections showing the CA3 subfield,
as indicated in the image in the box, from dorsal hippocampus of CTRL+saline- (A), CTRL+NPY- (B), TMT+saline- (C) and TMT+NPY- (D) treated rats.
Severe pyramidal neuronal loss is evident in both groups of TMT-treated animals (C, D). Scale bar: 160 mm.
doi:10.1371/journal.pone.0088294.g001
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pared with both CTRL groups (TMT+NPY vs CTRL+saline or
CTRL+NPY p,0.05), and in TMT+saline, when compared with
CTRL+saline (p,0.05). A significant upregulation of Ccnd1 was
detectable in both TMT-treated groups, with the highest
expression level observed in the TMT+NPY group (TMT+NPY
vs TMT+saline p,0.05; TMT+NPY vs CTRL+saline p,0.001;
TMT+NPY vs CTRL+NPY p,0.05; TMT+saline vs CTRL+
saline p,0.05). No modulation of Shh downstream-related genes
(Ptch1 and Kif3a) was detectable at this time point (p.0.05).
(Fig. 6, Table S3).
The expression levels of Npy1R, Npy2R, Npy5R were
evaluated in the four experimental groups 1 and 3 days after
NPY administration. A scrambled-NPY peptide-injected group
was also used as control. As expected, the expression pattern of
NpyRs indicated an up-regulation of Npy1R, Npy2R, Npy5R in
the NPY-treated groups (CTRL+NPY and TMT+NPY) when
compared with CTRL+saline group (p,0.05), while no significant
modulation was detectable in the scrambled-peptide- and saline-
treated animals (p.0.05). This was consistent with our previous
results [34] (Fig. S1).
Discussion
Although the pro-neurogenic role of exogenous NPY has been
extensively evaluated in both in vitro [11,66] and in vivo experi-
mental models of neurologic disorders [12,34], evidence that the
newly-generated cells survive and become functionally integrated
neurons has been poorly pursued. To address this issue, in the
present study the long-term in vivo effects and potential functional
impact of NPY administration in the TMT-model of neurode-
generation and TLE were explored at the molecular, morpholog-
ical and electrophysiological level.
In line with our previous experiments [34], we found that the
proliferative effect exerted on the hippocampal neurogenic niche
by a single i.c.v. administration of NPY leads to the production of
a significantly higher number of BrdU-positive newly-generated
neurons in TMT-treated animals, which is still evident 30 days
after treatment.
In this regard the relations among the various experimental
groups appear to be changed, when compared with our previous
study [34]. This is not surprising, bearing in mind the different
BrdU administration schedule, the different method used for
Figure 2. BrdU-immunoreactivity in the DG of the different experimental groups. A. Representative micrographs showing DAB-stained
BrdU-positive cells in the DG of CTRL+saline- (a), CTRL+NPY- (b), TMT+saline- (c), TMT+NPY (d) -treated rats: an increased number of BrdU-positive
newly-generated cells is evident in the DG of TMT+NPY-treated animals (d), when compared with the other groups (a, b, c). Scale bar: 40 mm. B. Bar
graphs showing the number of BrdU-stained nuclei in the DG of the different experimental groups. A significantly higher number of BrdU-positive
cells is evident in TMT+NPY-treated animals compared with the CTRL+saline group. The values are given as means 6 SD (*p,0.05).
doi:10.1371/journal.pone.0088294.g002
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quantitative analysis, as well as cell death and/or dilution of label
[67] possibly occurring during the longer temporal frame
investigated in this study.
No difference in the percentage of BrdU/NeuN double-labelled
neurons was detected among the different experimental groups,
thus indicating that the pool of newly-generated cells shows similar
features in terms of fate determination.
Our electrophysiological data indicate that TMT+NPY-treated
animals showed enhanced LTP which correlates with the
increased number of newly-born neurons integrated within the
DG. Recent studies have demonstrated that the specific contribu-
tion of newly-generated cells to LTP at the MPP-DGC synapses
can be unravelled performing experiments without blocking
GABAA receptors. Differently from more mature DG neurons,
the newly-generated cells integrated in the DG 30–45 days after
mitosis are indeed insensitive to GABAergic inhibition. In rodents
aCSF-LTP is absent when neurogenesis is chemically, physically
or genetically reduced, whereas it is enhanced when neurogenesis
is increased [53,59,61,68,69]. We found that aCSF-LTP was
similar in all groups except for the TMT+NPY group, in which it
was significantly enhanced, thus supporting the functional
Figure 3. BrdU/NeuN double-stained cells in the DG of the different experimental groups. A. Representative confocal microscopy
micrographs of CTRL+saline- (a), CTRL+NPY- (b), TMT+saline- (c), TMT+NPY (d) -treated rat DG sections double-labelled for NeuN (red) and BrdU
(green): a higher number of BrdU/NeuN-positive cells is evident in TMT+NPY-treated rats (d). Scale bar: 60 mm. B. The percentage of BrdU/NeuN
double-stained cells is unchanged in the various experimental groups. The values are given as means 6 S.D. (*p,0.05).
doi:10.1371/journal.pone.0088294.g003
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integration of newly-generated granule cells in the DG network of
TMT+NPY-treated animals.
Interestingly, in support of our morphological and physiological
results, we observed, in TMT+NPY-treated animals, a concom-
itant and significant up-regulation of the transcription factor Klf9,
considered a specific regulator of late-phase maturation of the
dentate granule neurons, being essential for their normal
integration into the local circuit [62]. Further support to our
conclusions is also given by the increased expression of Cdk5,
known to be involved not only in neuronal migration phenomena,
but also in dendritic pathfinding, spine formation and neuronal
maturation in the newborn cells of adult brain [63,70,71].
In order to provide elements useful to understand the molecular
cascade triggered by NPY administration and mediating the early
phases of its neurogenic effect during the TMT-induced neuro-
degenerative process, we explored the expression pattern of the
Shh pathway, which is crucially required to modulate neural
precursor behaviour in the adult DG [35,40], where it acts as a
potent mitogen on the neural progenitor cells of the hippocampal
niche [37].
The significantly higher levels of Shh mRNA found in the
TMT+NPY-treated group compared with TMT+saline treated
rats, along with the modulation of the downstream genes Ptch1
and Ccnd1 detected in CTRL+NPY-treated animals, may suggest
a direct role of NPY on Shh pathway modulation. This molecular
profile appeared to be especially marked at the earlier time point
explored (1 day), though the higher expression of Ccnd1 observed
in the TMT+NPY group 5 days after NPY administration may
also suggest a persistent effect. These findings are in line with the
proliferative effect known to be exerted by Shh on hippocampal
progenitors [36,37], thus further supporting its role in the
establishment and maintenance of the hippocampal niche [40].
Notably, the expression of Shh has been suggested to depend on
the expression of Sox2, a transcription factor required for the
maintenance of progenitor cells in the hippocampus [72], which,
according to our previous data, is significantly upregulated by
NPY administration in TMT-treated rats at the same time point
[34].
Our novel findings of a prolonged increase in Shh expression in
TMT+saline-treated groups is in line with previous evidence
suggesting a relationship between Shh expression and TLE in both
experimental models and human epilepsy [73,74]. It has been
hypothesised, in this regard, that the Shh pathway may be an
important mechanism through which epilepsy enhances adult
hippocampal neurogenesis [73]. Given that this pathway has been
proposed to exert neuroprotective effects in many neurologic
diseases [40,75,76], we may also hypothesise that the enhanced
Shh expression during TMT-induced neurodegeneration could be
part of the early activation of repair mechanisms in the injured
hippocampus, albeit with no reparative outcome. On the other
hand, a role in the development of neuronal death and TLE
cannot be excluded, as suggested by other groups [74].
More in general, in line with our previous findings, the
described effects of NPY administration are particularly evident
in the TMT-treated animals. Many studies have demonstrated
that several factors that are known to promote neural precursor
proliferation and survival (including nerve growth factor, brain-
Figure 4. Long-term potentiation (LTP) at medial perforant pathway (MPP)-dentate granule cell (DGC) synapses. A. Time course of
MPP-DGC LTP induced by high frequency stimulation (HFS) (delivered at time 0) in hippocampal slices from rats belonging to the four experimental
groups (CTRL+saline, CTRL+NPY, TMT+saline, TMT+NPY). Recordings were performed in normal aCSF (i.e, in the absence of GABAA receptor blockade)
and show enhanced LTP (aCSF-LTP) in slices from the TMT+NPY group compared to all the other experimental groups. Results are expressed as
percentages of baseline fEPSP amplitude (100%). B. Bar graphs comparing LTP magnitudes observed during the last 5 min of recording in the
different experimental groups. Error bars indicate S.E.M. values. *p,0.05 vs CTRL+saline-treated rats; #p,0.05 vs TMT+NPY group, (Student’s t test);
n.s., not significant.
doi:10.1371/journal.pone.0088294.g004
Figure 5. mRNA expression levels of Klf9 and Cdk5 in rat
hippocampus in the different experimental groups. Results of
quantitative real time-PCR obtained using the DDCt method for
calculation of the relative quantity (RQ) of Cdk5 and Klf9 genes tested
30 days after NPY administration. *p,0.05, calculated on mean DCt
across biological replicates.
doi:10.1371/journal.pone.0088294.g005
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derived neurotrophic factor, fibroblast growth factor-2, vascular
endothelial growth factor, and also Shh) are upregulated in the
hippocampus after acute seizures [77]. Thus we may speculate
that micro-environmental changes induced by epilepsy and/or
neurodegeneration could strengthen the NPY-mediated influence
Figure 6. mRNA expression levels of genes related to the Shh pathway in rat hippocampus in the different experimental groups.
Results of quantitative real time-PCR obtained using the DDCt method for the calculation of relative quantity (RQ) of Shh, Ccnd1, Ptch1 and Kif3a
genes at the three tested time points. *p,0.05, **p,0.001, calculated on mean DCt across biological replicates.
doi:10.1371/journal.pone.0088294.g006
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on the hippocampal niche, thus promoting significant neurogenic
outcomes.
The present study provides novel evidence that a single NPY
administration during TMT-induced neurodegeneration triggers
early activation of the Shh pathway and exerts long-term effects on
dentate neurogenesis, resulting in the production of a population
of functionally integrated granule cells. It is well known that this
population of adult-born neurons plays a key role in learning and
memory processes [78,79], thus contributing to the physiological
functions of the hippocampus. Taking into account the relevance
of hippocampal dysfunction in TLE and neurodegeneration, our
observations offer information that is potentially useful in the light
of possible restorative outcomes.
Supporting Information
Figure S1 mRNA expression levels of NPY receptor
genes after NPY-, scrambled-NPY- or saline adminis-
tration in TMT-treated and CTRL rats. A. The histogram
shows the results of quantitative real time-PCR obtained using the
DDCt method for calculation of the relative quantity (RQ) of NPY
receptor genes (NPY1R, NPY2R, NPY5R) tested 1 and 3 days
after NPY-, scrambled NPY- or saline administration in TMT-
treated and CTRL rat hippocampi. *p,0.05, calculated on mean
DCt across biological replicates. B. The table shows mean DCt,
SD, SEM and p values referred to qPCR results.
(TIF)
Table S1 Oligonucleotide primer sequences. The table
indicates the oligonucleotide primer sequences used in qPCR
analysis.
(DOC)
Table S2 Cell count results of double-stained BrdU/
NeuN positive cells. The table indicates the values of the total
numbers of BrdU/NeuN double-stained cells 6 SD in the DG
granular layer of the different experimental groups. Statistical
analysis showed that the number of BrdU/NeuN double-labelled
cells was significantly higher in TMT+NPY-treated rats compared
with both CTRL groups (Two-way ANOVA, F1,8 = 32.5 p,
0.001) and TMT+saline group (Two-way ANOVA, F1,8 = 5.37
p,0.05).
(DOC)
Table S3 Mean DCt values, SD, SEM and p values
referred to qPCR analysis. Table S3 shows the values of
mean DCt, SD, SEM and p referred to qPCR analysis of Shh,
Ptch1, Ccnd1, Kif3a gene expression performed 1, 3 and 5 days
after NPY treatment (A, B, C) and to Klf9 and Cdk5 gene
expression performed 30 days after NPY treatment (D).
(DOC)
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